Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data.
Lee CW, Ahn JM, Cavalcante R, Sotomi Y, Onuma Y, Suwannasom P, Tenekecioglu E, Yun SC, Park DW, Kang SJ, Lee SW, Kim YH, Park SW, Serruys PW, Park SJ.
JACC Cardiovasc Interv. 2016 Dec 26;9(24):2481-2489. doi: 10.1016/j.jcin.2016.10.008.
Comparative long-term efficacy and safety of drug-eluting stent versus coronary artery bypass grafting in ostial left main coronary artery disease: analysis of the MAIN-COMPARE registry.
Lee SW, Kim SH, Kim SO, Han S, Kim YH, Park DW, Kang SJ, Lee CW, Park SW, Park SJ.
Catheter Cardiovasc Interv. 2012 Aug 1;80(2):206-12. doi: 10.1002/ccd.23369. Epub 2012 Jan 10.
Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.
Tiroch K, Mehilli J, Byrne RA, Schulz S, Massberg S, Laugwitz KL, Vorpahl M, Seyfarth M, Kastrati A; ISAR-LEFT MAIN Study Investigators.
JACC Cardiovasc Interv. 2014 Jan;7(1):29-36. doi: 10.1016/j.jcin.2013.08.013. Epub 2013 Dec 11.
Coronary artery bypass grafting versus drug-eluting stent implantation for left main coronary artery disease (from a two-center registry).
Kang SH, Park KH, Choi DJ, Park KW, Chung WY, Lim C, Kim KB, Kim HS.
Am J Cardiol. 2010 Feb 1;105(3):343-51. doi: 10.1016/j.amjcard.2009.09.036.
Comparison of 5-year outcomes in patients with and without unprotected left main coronary artery disease after treatment with sirolimus-eluting stents: insights from the j-Cypher registry.
Toyofuku M, Kimura T, Morimoto T, Hayashi Y, Shiode N, Nishikawa H, Nakao K, Shirota K, Kawai K, Hiasa Y, Kadota K, Nozaki Y, Isshiki T, Sone T, Mitsudo K; j-Cypher Registry Investigators.
JACC Cardiovasc Interv. 2013 Jul;6(7):654-63. doi: 10.1016/j.jcin.2013.03.015.
Twelve-year outcomes after revascularization for ostial/shaft lesions in unprotected left main coronary artery.
Yu XP, Li Y, He JQ, Jin ZN.
J Geriatr Cardiol. 2020 Jun;17(6):338-343. doi: 10.11909/j.issn.1671-5411.2020.06.004.
Clinical outcome after management of unprotected left main in-stent restenosis after bare metal or drug-eluting stents.
Chen SL, Xu B, Mintz G, Ye F, Zhang JJ, Kan J, Sun XW, Zhang AP, Chen JG, Qian J, Kwan TW.
Chin Med J (Engl). 2010 Apr 5;123(7):794-9.
Drug-eluting Vein Graft with Acetylsalicylic Acid-Ticagrelor-Unfractionated Heparin Complex Inhibits Early Graft Thrombosis.
Akşit E, Kurt T, Büyük B, Çokkalender Ö.
Balkan Med J. 2020 Aug 11;37(5):269-275. doi: 10.4274/balkanmedj.galenos.2020.2020.1.128. Epub 2020 May 1.
Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) Registry.
Park DW, Kim YH, Yun SC, Lee JY, Kim WJ, Kang SJ, Lee SW, Lee CW, Kim JJ, Choo SJ, Chung CH, Lee JW, Park SW, Park SJ.
J Am Coll Cardiol. 2010 Oct 19;56(17):1366-75. doi: 10.1016/j.jacc.2010.03.097.
Dedicated bifurcation paclitaxel-eluting stent BiOSS Expert in the treatment of distal left main stem stenosis.
Bil J, Gil RJ, Vassilev D, Rzezak J, Kulawik T, Pawlowski T.
J Interv Cardiol. 2014 Jun;27(3):242-51. doi: 10.1111/joic.12119. Epub 2014 Apr 7.
